Abstracts - PAGE Meeting (Population Approach Group Europe)

Abstracts (21)

I-31Maddlie Bardol

Population pharmacokinetics of fentanyl in very preterm infants

Wednesday 09:50-11:15

I-79Sinziana Cristea

Untangling maturation functions for kidney transporters using a combined population pharmacokinetics and physiology-based pharmacokinetics approach

Wednesday 09:50-11:15

I-80Salvatore D'Agate

Population Pharmacokinetics and Effect of Variable Renal Function on the Exposure to Aciclovir in Term and Pre-term Neonates

Wednesday 09:50-11:15

II-08Jean Lavigne

Population Pharmacokinetics of Piperacillin-Tazobactam Extended Infusions in Paediatric Population

Wednesday 15:10-16:40

II-47Danica Michalickova

Pharmacokinetics of phenobarbital in neonates on extracorporeal membrane oxygenation

Wednesday 15:10-16:40

II-74Soumya Perinparajah

Pharmacodynamics of rituximab on B cells in paediatric post-HSCT patients with EBV

Wednesday 15:10-16:40

III-01Clémence Rigaux

An approach for reducing the sample sizes of pediatric trials in Type 2 Diabetes Mellitus: longitudinal analysis versus standard analyses

Thursday 09:55-11:20

III-11Louis Sandra

A population pharmacokinetic model for propofol in (pre)term neonates and infants independently accounting for size, gestational age (GA) and postnatal age (PNA).

Thursday 09:55-11:20

III-23Erik Sjögren

A PBPK Framework to Predict Drug Exposure in Malnourished Children

Thursday 09:55-11:20

III-25Elena Soto

Population Pharmacokinetic (PopPK) Modelling and Simulation of Pregabalin to Support Dose Recommendation in Paediatric Patients 1 month to <4 years of Age with Partial Onset Seizures (POS)

Thursday 09:55-11:20

III-27Viktoria Stachanow

Does dried blood spot data enrich our understanding of hydrocortisone pharmacokinetics in paediatric patients with adrenal insufficiency?

Thursday 09:55-11:20

III-49Parth Upadhyay

Exploring the Relationship Between Midazolam Concentrations And Level Of Sedation In Critically-Ill Mechanically Ventilated Children Using Markov Modelling

Thursday 09:55-11:20

III-51Pavan Vaddady

Application of Bayesian Methodology to Inform Imipenem/Relebactam Pediatric Study Design

Thursday 09:55-11:20

III-55Louvina van der Laan

Pharmacokinetics and drug-drug interactions of lamivudine and abacavir administered with antituberculosis drugs in HIV-infected children with multidrug-resistant tuberculosis

Thursday 09:55-11:20

III-57Tamara van Donge

Methadone dosing strategies in preterm neonates can be simplified

Thursday 09:55-11:20

IV-09Aline Engbers

Postnatal age, gestational age and small for gestational age drive the pharmacokinetics of ibuprofen enantiomers in very preterm neonates with patent ductus arteriosus

Thursday 15:25-16:50

IV-10Muhammad Faisal

Simultaneous semi-mechanistic population pharmacokinetic analysis of enalapril and enalaprilat in serum and urine following the administration of child appropriate oro-dispersible mini-tablets.

Thursday 15:25-16:50

IV-31Ferran Gonzalez

Pharmacokinetic model development for total and free vancomycin in critically ill children

Thursday 15:25-16:50

IV-35Iztok Grabnar

Oxcarbazepine and its active metabolite 10-monohydroxycarbamazepine clearance maturation in paediatric patients with epilepsy

Thursday 15:25-16:50

IV-42Lutz Harnisch

Dose Selection Process for Younger Children Participating in a Phase 3 Study to Evaluate the Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-occlusive Crisis in Hospitalized Patients With Sickle Cell Disease

Thursday 15:25-16:50

IV-43Paul Healy

PKPD bridging and extrapolation of efficacy for the use of gabapentin and tramadol in paediatric chronic pain.

Thursday 15:25-16:50